Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland
June 08, 2015 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Jun 8, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, announced that three invited...
Vaccine Improvement Patent Awarded to iBio
May 04, 2015 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - May 4, 2015) - iBio, Inc. (NYSE MKT: IBIO) a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a...
iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics
April 27, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Apr 27, 2015) - iBio, Inc. (NYSE MKT: IBIO), has engaged Caliber Biotherapeutics LLC to scale-up and produce materials for clinical development of the first of iBio's...
iBio European Plague Vaccine Patent Emerges From Opposition Period
March 30, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Mar 30, 2015) - iBio, Inc. (NYSE MKT: IBIO), today announced it received notice from the European Patent Office that the opposition period expired for a bio-defense...
iBio Adds Anthrax Antibodies to Product Pipeline
February 25, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Feb 25, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of US...
iBio Receives US and European Patents for Protein Expression Technology
February 12, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Feb 12, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issuance of...
iBio Adds to iBioModulator Portfolio and Product Pipeline
February 04, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Feb 4, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a new...
iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting
December 10, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Dec 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in biotechnology for developing and manufacturing plant-made pharmaceutical products, will provide shareholders and...
iBio Grants Caliber License for Production of Antibodies Targeting Ebola
November 10, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Nov 10, 2014) - iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch™...
iBio Expands Exclusive Product Collaboration With Novici Biotech
October 22, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 22, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC...